Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Androgens and prostate cancer.

Alan I So1, Antonio Hurtado-Coll, Martin E Gleave

  • 1The Prostate Centre at the Vancouver General Hospital, University of British Columbia, 2660-Oak Street, Vancouver, BC, V6H 3Z6 Canada. aso@vanhosp.bc.ca

World Journal of Urology
|October 31, 2003
PubMed
Summary

Androgens are crucial in prostate cancer. Understanding how prostate cancer becomes resistant to hormone therapy is essential for developing new treatments and improving patient survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadir.

Future oncology (London, England)·2026
Same author

PARP Inhibition in Prostate Cancer: Current Status, Resistance Mechanisms, and Clinical Challenges.

Cells·2026
Same author

The predictive value of lesion density in enhancing multiparametric MRI for detecting clinically significant prostate cancer.

Urologic oncology·2026
Same author

Examining the association between real-world extended vs. standard pelvic lymph node dissection and early and late oncologic outcomes in men undergoing radical prostatectomy.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2025
Same author

Summary of changes in the 2025 Canadian Urological Association-Canadian Urologic Oncology Group guideline on metastatic castration-resistant prostate cancer.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2025
Same author

Comparative analysis of apixaban vs. enoxaparin for thromboprophylaxis after radical cystectomy A single-center, observational, before-after study.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2025

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Huggins and Hodges established the role of androgens in prostate cancer over 60 years ago.
  • The relationship between androgens and prostate cancer is complex, involving multiple signaling pathways.
  • Prostate cancer can become resistant to hormonal therapy, leading to recurrence and progression.

Purpose of the Study:

  • To review the mechanisms of androgen action in prostate cancer.
  • To examine the relationship between androgens and hormonal therapy.
  • To explore the mechanisms underlying hormonal resistance in prostate cancer.

Main Methods:

  • Literature review of established and emerging research on androgen action.
  • Analysis of signaling cascades and protein coactivators involved in prostate cancer.
  • Examination of documented cases of treatment resistance.

Main Results:

  • Androgen signaling is fundamental to prostate cancer development and progression.
  • Hormonal therapies initially effective can be overcome by resistant phenotypes.
  • Understanding resistance mechanisms is key to overcoming therapeutic limitations.

Conclusions:

  • Further research into androgen action and resistance is critical for improving prostate cancer survival.
  • Novel therapeutic strategies must address the emergence of hormone-resistant prostate cancer.
  • A comprehensive understanding of hormonal interplay is necessary for effective prostate cancer treatment.

Related Experiment Videos